CytImmune Sciences cytimmune.com


Public list: Pharma Startups (6570) Cancer Therapeutics (1180)

CytImmune Sciences is a clinical stage nanomedicine company with a core focus on the discovery, development and commercialization of multifunctional, tumor-targeted therapies.

CytImmune Sciences is a clinical stage nanomedicine company with a core focus on the discovery, development and commercialization of multifunctional, tumor-targeted therapies.

Company (Alive / Active)

Phone: 301-825-3041

Fax:

15010 Broschart Road

Rockville, 20850
Maryland, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
CytImmune Sciences $10.4M Apr 27, 2020
See all 14 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related CytImmune Sciences Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 5 investors

Board Members

Competitors

Company Status Description Investors

Glaukos

San Clemente, California, United States
IPO / Went publicGlaukos (NYSE: GKOS) is an ophthalmic medical technology company focused on the development and commercialization of products and procedures to transform the treatment of glaucoma, one of the leading causes of blindness. Glaukos developed Micro-Invasive Glaucoma Surgery, or MIGS, in order to improve the traditional glaucoma treatment and management paradigm.Login to see details

Humanetics Corporation

Minneapolis, Minnesota, United States
Alive / ActiveHumanetics Corporation is a clinical-stage pharmaceutical company engaged in developing and commercializing products to enhance human health and wellbeing in markets with urgent and unmet needs with a focus on radiation modulators for oncology, medical imaging and medical countermeasure uses.Login to see details
See all 14 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Colloidal metal compositions and methods Feb 18, 2010 Jul 22, 2014 Patent
Thiolated paclitaxels for reaction with gold nanoparticles as drug delivery agents Nov 10, 2008 Oct 15, 2013 Patent
Methods and compositions for the production of monoclonal antibodies Apr 20, 2011 May 07, 2013 Patent
Method for delivering a cytokine using a colloidal metal Sep 26, 2003 Mar 20, 2012 Patent
Colloidal metal compositions and methods Oct 24, 2007 Jul 05, 2011 Patent
See all 9 patents